Is NxStage Medical, Inc. (NXTM) A Good Stock To Buy Right Now?

Seeing as NxStage Medical, Inc. (NASDAQ:NXTM) has witnessed falling interest from the entirety of the hedge funds we track, it’s easy to see that there exists a select few fund managers that decided to sell off their entire stakes last quarter. At the top of the heap, Mitchell Blutt’s Consonance Capital Management dropped the biggest stake of all the hedgies watched by Insider Monkey, worth close to $18.1 million in stock, and Paul Marshall and Ian Wace’s Marshall Wace LLP was right behind this move, as the fund sold off about $4.5 million worth. These bearish behaviors are important to note, as total hedge fund interest fell by 1 funds last quarter.

Let’s also examine hedge fund activity in other stocks similar to NxStage Medical, Inc. (NASDAQ:NXTM). We will take a look at Crestwood Equity Partners LP (NYSE:CEQP), Rexford Industrial Realty Inc (NYSE:REXR), TopBuild Corp (NYSE:BLD), and Allegheny Technologies Incorporated (NYSE:ATI). This group of stocks’ market valuations match NXTM’s market valuation.

As you can see these stocks had an average of 13 hedge funds with bullish positions and the average amount invested in these stocks was $133 million. That figure was $323 million in NXTM’s case. TopBuild Corp (NYSE:BLD) is the most popular stock in this table. On the other hand Crestwood Equity Partners LP (NYSE:CEQP) is the least popular one with only 7 bullish hedge fund positions. Compared to these stocks NxStage Medical, Inc. (NASDAQ:NXTM) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.